Chemmart Solifenacin solifenacin succinate 5 mg film coated tablets blister

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

solifenacin succinate, Quantity: 5 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

Solifenacin succinate

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: hyprolose; iron oxide yellow; titanium dioxide; magnesium stearate; polyvinyl alcohol; lactose; macrogol 8000; purified talc; croscarmellose sodium

Mode d'administration:

Oral

Unités en paquet:

30

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Descriptif du produit:

Visual Identification: Light yellow coloured, round shaped, biconvex, film-coated tablets, engraved with 'APO' on one side and 'S 5' on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 12 Months; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2016-01-12